National Cancer Institute - Activities to Promote Research Collaboration (NCI-APRC)

National Cancer Institute - Activities to Promote Research Collaboration (NCI-APRC)
ACTIVITIES TO PROMOTE RESEARCH COLLABORATIONS (APRC) NATIONAL CANCER INSTITUTE ACTIVITIES TO PROMOTE RESEARCH COLLABORATIONS FY2009 Guidelines and Information for Applicants Revised 3/31/09 PURPOSE The American Recovery and Reinvestment Act of 2009 (Recovery Act or ARRA), Public Law 111-5, was signed into law on February 17, 2009 with the purpose of stimulating the American economy through job preservation and creation, infrastructure investment, energy efficiency and science, and other means. The Recovery Act provides NIH with up to $10.4 billion to be obligated over two years for a variety of biomedical research and research support activities. Some funds directed to the National Cancer Institute (NCI) have been designated for an initiative known as the NCI-Activities to Promote Research Collaboration (NCI-APRC). Through the NCI-APRC program, the NCI encourages requests for supplemental funding in FY2009 for existing NCI-funded research projects to support and encourage new multidisciplinary scientific collaborations among NCI grantees, as well as with other members of the scientific community. The NCI-APRC Program can support novel collaborative activities in cancer biology, cancer control and population sciences, cancer surveillance, cancer prevention, health services and outcomes research, and cancer treatment and diagnosis that bring together new ideas and approaches from disparate scientific disciplines. The proposed NCI-APRC activities must be within the overall scope of the active parent award and the collaborative activity must be new. The NCI-APRC program is anticipated to be highly competitive; 12-15 supplements will be funded for up to 2 years each. Before submission, all grantees must contact their designated NCI Program Director to discuss the planned collaboration and application. If applicants do not first contact their Program Director, the application will not be considered. This is a one-time announcement with a single receipt date of May 1, 2009. Late applications will not be accepted. Requests must be submitted as described in these APRC Program guidelines. Some eligibility restrictions apply. The NIH Center for Scientific Review (CSR) is not involved in receipt and processing of these requests. This document describes the: (1) purpose; (2) background; (3) administrative mechanism to promote research collaborations; (4) eligibility requirements; (5) review considerations and criteria; (6) preparing an administrative supplement request; (7) post-award requirement; (8) terms of award, (9) administrative and national policy requirements, (10) reporting, (11) application deadline; (12) electronic submission, (13) mailing address for paper submission; and (14) contact information for inquiries. For Full Document HTML / DOC / PDF

NATIONAL CANCER INSTITUTE

ACTIVITIES TO PROMOTE RESEARCH COLLABORATIONS

FY2009 Guidelines and Information for Applicants

Revised 3/31/09

PURPOSE

The American Recovery and Reinvestment Act of 2009 (Recovery Act or ARRA), Public Law 111-5, was signed into law on February 17, 2009 with the purpose of stimulating the American economy through job preservation and creation, infrastructure investment, energy efficiency and science, and other means. The Recovery Act provides NIH with up to $10.4 billion to be obligated over two years for a variety of biomedical research and research support activities. Some funds directed to the National Cancer Institute (NCI) have been designated for an initiative known as the NCI-Activities to Promote Research Collaboration (NCI-APRC).

Through the NCI-APRC program, the NCI encourages requests for supplemental funding in FY2009 for existing NCI-funded research projects to support and encourage new multidisciplinary scientific collaborations among NCI grantees, as well as with other members of the scientific community. The NCI-APRC Program can support novel collaborative activities in cancer biology, cancer control and population sciences, cancer surveillance, cancer prevention, health services and outcomes research, and cancer treatment and diagnosis that bring together new ideas and approaches from disparate scientific disciplines. The proposed NCI-APRC activities must be within the overall scope of the active parent award and the collaborative activity must be new.

The NCI-APRC program is anticipated to be highly competitive; 12-15 supplements will be funded for up to 2 years each. Before submission, all grantees must contact their designated NCI Program Director to discuss the planned collaboration and application. If applicants do not first contact their Program Director, the application will not be considered.

This is a one-time announcement with a single receipt date of May 1, 2009. Late applications will not be accepted. Requests must be submitted as described in these APRC Program guidelines. Some eligibility restrictions apply. The NIH Center for Scientific Review (CSR) is not involved in receipt and processing of these requests.

This document describes the: (1) purpose; (2) background; (3) administrative mechanism to promote research collaborations; (4) eligibility requirements; (5) review considerations and criteria; (6) preparing an administrative supplement request; (7) post-award requirement; (8) terms of award, (9) administrative and national policy requirements, (10) reporting, (11) application deadline; (12) electronic submission, (13) mailing address for paper submission; and (14) contact information for inquiries.

For Full Document HTML / DOC / PDF